Tumor News and Research

RSS

New CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations

Genomic studies of cancer patients have revealed thousands of mutations linked to tumor development.

11 May 2023

Fatty liver promotes the spread of colorectal cancer to the liver

Investigators at Cedars-Sinai Cancer found that fatty liver, a condition closely associated with obesity, promotes the spread of colorectal cancer to the liver.

11 May 2023

Targeting uncontrolled inflammation may make tumors more responsive to treatment

Van Andel Institute scientists have pinpointed how a specific gene mutation triggers an inflammatory cascade that may drive development of treatment-resistant cancers.

11 May 2023

Research sheds light on the early cellular events that give rise to pancreatic cancer

Discussions of cancer often stress the genetic mutations that drive disease by altering the normal function of cellular proteins.

11 May 2023

PBMs, the brokers who control drug prices, finally get Washington’s attention

For two decades, patients and physicians eagerly awaited a lower-cost version of the world's bestselling drug, Humira, while its maker, AbbVie, fought off potential competitors by building a wall of more than 250 patents around it.

11 May 2023

New tool launched to make ESMO Clinical Practice Guidelines easier to use in routine clinical practice

ESMO, the leading professional organization for medical oncology, today announced the launch of a new tool designed to make the renowned ESMO Clinical Practice Guidelines (CPGs) easier to use in oncologists' routine clinical practice and support optimal decision-making in a rapidly evolving medical field.

10 May 2023

Silenced p16 gene can drive colorectal cancer progression

Colorectal cancer is the fourth most common and second deadliest cancer. How colorectal cancer develops is not well understood, but a team led by researchers at Baylor College of Medicine reports in the Journal of Experimental & Clinical Cancer Research that silencing the gene p16, even though the DNA itself does not change, can drive colorectal cancer progression in animal models.

10 May 2023

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

A new research perspective was published in Oncotarget's Volume 14 on May 4, 2023, entitled, "Using cancer proteomics data to identify gene candidates for therapeutic targeting."

10 May 2023

The potential variations in sperm quality of infertile patients during the COVID-19 pandemic

A recent study investigated how SARS-CoV-2 infection affected the semen quality of infertile men in Tunisia.

10 May 2023

New SNAP approach to customizing T cell-based immunotherapies

University of Pittsburgh researchers have developed a universal receptor system that allows T cells to recognize any cell surface target, enabling highly customizable CAR T cell and other immunotherapies for treating cancer and other diseases.

9 May 2023

Vitamin D intake could reduce cancer mortality

Vitamin D intake could reduce cancer mortality in the population by twelve percent - provided the vitamin is taken daily.

9 May 2023

Boosting gut health with short-chain fatty acids

Research paper provides an overview of short-chain fatty acids (SCFAs) and their role in regulating gut homeostasis. It also discusses SCFA-producing bacteria and potential therapeutic approaches to boost SCFA levels in the gut to treat related diseases.

9 May 2023

High-grade gliomas remodel neural circuits: promoting tumor progression and impaired cognition

Researchers investigated whether functional connectivity between glioblastoma and the brain affected neural circuits.

9 May 2023

High-resolution atlas illustrates the development of human retina

What cell types are found in which human tissue, and where? Which genes are active in the individual cells, and which proteins are found there?

8 May 2023

Can intermittent fasting tackle obesity-related inflammation?

Research reviews the effects of two forms of intermittent fasting, time-restricted eating (TRE) and alternate-day fasting (ADF), on body weight and key circulating inflammatory markers (CRP, TNF-alpha, and IL-6) in adults with obesity. The results suggest that intermittent fasting has little or no effect on key inflammatory markers, but more research is needed to confirm these findings.

8 May 2023

Tumor News and Research

New CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations

Fatty liver promotes the spread of colorectal cancer to the liver

Targeting uncontrolled inflammation may make tumors more responsive to treatment

Research sheds light on the early cellular events that give rise to pancreatic cancer

PBMs, the brokers who control drug prices, finally get Washington’s attention

New tool launched to make ESMO Clinical Practice Guidelines easier to use in routine clinical practice

Silenced p16 gene can drive colorectal cancer progression

Leveraging proteomics datasets to discover potential therapeutic targets for cancer patients

The potential variations in sperm quality of infertile patients during the COVID-19 pandemic

New SNAP approach to customizing T cell-based immunotherapies

Vitamin D intake could reduce cancer mortality

Boosting gut health with short-chain fatty acids

High-grade gliomas remodel neural circuits: promoting tumor progression and impaired cognition

High-resolution atlas illustrates the development of human retina

Can intermittent fasting tackle obesity-related inflammation?

Upregulated expression of many LY6 genes linked to poor survival in endometrial cancer patients

Cancer-fighting immune cells can fuel their ability to attack tumors

Intratumoral bacteria linked with natural purple photosynthetic bacteria show strong anticancer efficacy

Researchers evaluate the dual-therapeutic effect of gene therapy in mouse model of osteosarcoma

Breast cancer tumors disrupt the development of an immune response to favor their own growth

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News